Low Intensity Focused Ultrasound in ASD

Starting soon · Phase 1

Conditions studied: Autism Spectrum Disorder

In brief

This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.

Key facts

Study ID

NCT07225322

Run by

Medical University of South Carolina

People needed

20

Starts

2026-07-01

Expected to finish

2027-12-01

Last updated by the study team

2026-05-22

Who can join

Age: 13 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 13-25
• Diagnosis of ASD (DSM-5)
• Full Scale IQ > 70
• Verbal communication
• Stable medication for ≥1 month
• Ability to consent or assent with guardian consent

You may not qualify if…

• MRI or LIFU contraindications
• Recent investigational drug/device use
• Neurological illness (e.g., epilepsy, TBI)
• Substance use disorder
• Sensory/motor impairments preventing task completion

Where it is running

• MUSC Brain Stimulation Offices — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.